Clinical outcomes of mitral valve repair in patients with rheumatic mitral valve disease and risk factors for long-term prognosis

doi:10.3969/j.issn.1006-7795.2025.05.018

Abstract

Abstract: Objective To retrospectively analyze the clinical outcomes of mitral valve repair MVR for treating rheumatic mitral valve disease. Methods A total of 537 patients with rheumatic mitral valve disease who underwent surgical repair at the Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, from January 2016 to August 2022 were retrospectively included. Clinical and follow-up data were collected. Kaplan-Meier survival curves were constructed to calculate event-free survival rates for the cohort. Additionally, multivariate Cox regression analysis was employed to identify independent risk factors affecting patient prognosis. Results The mean age of all patients was (57.8 ± 7.5) years, with 144 (26.8%) males and 393 (73.2%) females. The median follow-up time for the cohort was 36.7 months. Survival analysis revealed that the 5-year composite endpoint-free survival rate was 94.1%, the 5-year overall survival rate was 96.7%, and the 5-year freedom from mitral valve reoperation rate was 97.2%. Multivariate Cox regression analysis identified systolic pulmonary artery pressure as an independent risk factor for adverse prognosis (P<0.05). Conclusion Mitral valve repair can achieve favorable outcomes in appropriately selected patients with rheumatic mitral valve disease, while systolic pulmonary artery pressure serves as an independent risk factor for an adverse prognosis.

Key words: rheumatic heart disease, mitral stenosis, mitral valve repair, clinical outcomes, prognosis, risk factors

CLC Number:

R654

Li Xin, Jiang Wenjian, Han Jie, Zhang Hongjia. Clinical outcomes of mitral valve repair in patients with rheumatic mitral valve disease and risk factors for long-term prognosis [J]. Journal of Capital Medical University, 2025, 46(5): 885-891.

References

［1］ Watkins D A, Johnson C O, Colquhoun S M, et al. Global, regional, and national burden of rheumatic heart disease, 1990-2015［J］. N Engl J Med, 2017, 377(8): 713-722.
［2］ Yang Y, Wang Z W, Chen Z, et al. Current status and etiology of valvular heart disease in China: a population-based survey［J］. BMC Cardiovasc Disord, 2021, 21(1): 339.
［3］ Dillon J, Yakub M A, Kong P K, et al. Comparative long-term results of mitral valve repair in adults with chronic rheumatic disease and degenerative disease: is repair for “burnt-out” rheumatic disease still inferior to repair for degenerative disease in the current era?［J］. J Thorac Cardiovasc Surg, 2015, 149(3): 771-779.
［4］ Thomas M P, Badhwar V. A three-step technique for repair of rheumatic disease of the mitral valve［J］. Cardiol Young, 2014, 24(6): 1104-1107.
［5］ Waikittipong S. Mitral valve repair for rheumatic mitral regurgitation: mid-term results［J］. Asian Cardiovasc Thorac Ann, 2015, 23(6): 658-664.
［6］ Luo T G, Meng X, Yan Z G, et al. Commissuroplasty as a main operative technique in rheumatic mitral valve repair: surgical experiences and mid-term results［J］. Heart Lung Circ, 2020, 29(6): 940-948.
［7］ Otto C M, Nishimura R A, Bonow R O, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines［J］. J Thorac Cardiovasc Surg, 2021, 162(2): e183-e353.
［8］ Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European society of cardiology(ESC)and the European association for cardio-thoracic surgery(EACTS)［J］. Rev Esp Cardiol, 2022, 75(6): 524.
［9］ Kim W K, Kim H J, Kim J B, et al. Clinical outcomes in 1731 patients undergoing mitral valve surgery for rheumatic valve disease［J］. Heart, 2018, 104(10): 841-848.
［10］ Fu J T, Li Y, Zhang H B, et al. Outcomes of mitral valve repair compared with replacement for patients with rheumatic heart disease［J］. J Thorac Cardiovasc Surg, 2021, 162(1): 72-82, e7.［11］ Chen S W, Chen C Y, Chien-Chia W V, et al. Mitral valve repair versus replacement in patients with rheumatic heart disease［J］. J Thorac Cardiovasc Surg, 2022, 164(1): 57－67, e11.
［12］ Liao Y B, Wang T K M, Wang M T M, et al. Meta-analysis of mitral valve repair versus replacement for rheumatic mitral valve disease［J］. Heart Lung Circ, 2022, 31(5): 705-710.
［13］ Jiang Y F, Wang C, Li G, et al. Clinical outcomes following surgical mitral valve repair or replacement in patients with rheumatic heart disease: a meta-analysis［J］. Ann Transl Med, 2021, 9(3): 204.
［14］ Fu J T, Popal M S, Zhang H B, et al. A meta-analysis of late outcomes of mitral valve repair in patients with rheumatic heart disease［J］. J Thorac Dis, 2017, 9(11): 4366-4375.
［15］ Luo T G, Meng X. Rheumatic mitral valve repair: the score procedure［J］. Asian Cardiovasc Thorac Ann, 2020, 28(7): 377-380.

[1]	Yang Shuyue, Liu Sifan, Ji Xu, Zhao Mengran, Zhang Zheng, Li Peng. Analysis on risk factors of adverse events after non-sedated esophagogastroduo-denoscopy [J]. Journal of Capital Medical University, 2025, 46(4): 676-681.
[2]	Mao Wenping, Han Qian, Jiao Fengwei, Wang Jing, Huang Kewu. The predictive value of serum β2M level for prognosis in exacerbated COPD and the results of when it is compared with other inflammatory markers [J]. Journal of Capital Medical University, 2025, 46(4): 718-723.
[3]	Song Jiugang, Wang Chunsaier, Zhang Qian, Li Peng, Zhang Shutian. Analysis of clinical characteristics of 470 cases of esophageal foreign body impaction by gastroscopy intervention in adults [J]. Journal of Capital Medical University, 2025, 46(3): 576-580.
[4]	Qin Yunlong, Zhou Jin, Liu Meng, Luo Kaifa, Wang Anjing, Wang Di, Zhao Jin, Sun Shiren. Analysis of clinicopathological characteristics and prognosis of malignant hypertensive nephrosclerosis [J]. Journal of Capital Medical University, 2024, 45(5): 838-845.
[5]	Zhang Dakun, Zhang Hongbo, Dong Dexin, Gao Xiang, Zheng Han, Zhang Lang. Early diagnosis and treatment of urinary sepsis after ureteroscopic lithotripsy of upper urinary tract stones [J]. Journal of Capital Medical University, 2024, 45(5): 870-874.
[6]	Xu Jinjie, Wang Meiti, Wang Chengrui, Jin Wenqing, Ren Yanping, Wang Wei. Study on the correlation between suicide in patients with bipolar disorder depressive episodes and IgA [J]. Journal of Capital Medical University, 2024, 45(1): 52-60.
[7]	Tian Xiaoru, Qian Kun, Zhang Peilong, Zhang Yi. Analysis of risk factors for postoperative complications after uniportal-VATS lobectomy or segmentectomy in elderly patients with lung cancer [J]. Journal of Capital Medical University, 2024, 45(1): 118-126.
[8]	Liu Juan, Wang Wenjing, Zhao Guiping, Wang Yongjun, Li Peng, Wu Yongdong, Zhang Shutian. Risk factors associated with recurrence of achalasia after peroral endoscopic myotomy [J]. Journal of Capital Medical University, 2023, 44(6): 978-981.
[9]	Wang Chengwei, Yuan Linsong, Zhou Yang, Wang Huiwen. Analysis of risk factors of delirium and agitation during anesthesia emergence in pediatric neurosurgery patients [J]. Journal of Capital Medical University, 2023, 44(2): 244-247.